or Try an Advanced Search...

    Technical Analysis for XRTX - XORTX Therapeutics Inc.

    Grade Last Price % Change Price Change
    F 1.29 -8.02% -0.11
    XRTX closed down 8.02 percent on Friday, November 15, 2024, on 11 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical XRTX trend table...
    Date Alert Name Type % Chg
    Stochastic Buy Signal Bullish 0.00%
    Gapped Down Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Outside Day Range Expansion -8.02%
    Wide Bands Range Expansion -8.02%
    Oversold Stochastic Weakness -8.02%
    Stochastic Reached Oversold Weakness -0.95%
    Earnings Movers Other -0.95%
    Wide Bands Range Expansion -0.95%
    Gapped Up Strength -0.95%
    Older End-of-Day Signals for XRTX ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance 1 day ago
    60 Minute Opening Range Breakout 1 day ago
    60 Minute Opening Range Breakdown 1 day ago
    Fell Below Previous Day's Low 1 day ago
    Down 10% 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    XRTX Chart by TradingView
    Basic chart:

    Profile

    XORTX Therapeutics Inc. is a pharmaceutical company with two clinically advanced products in development – XRx-008 for Autosomal Dominant Polycystic Kidney Disease (ADPKD), XRx-101 for Coronavirus / COVID-19 infection and XRx-225 is a pre-clinical stage program for Type 2 Diabetic Nephropathy (T2DN). XORTX is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. At XORTX Therapeutics, we are dedicated to developing medications to improve the quality of life and future health of patients.
    Classification
    Sector: Technology
    Industry: Data Storage
    Keywords: Pharmaceutical Organ Systems Infection Kidney Disease Kidney Diabetic Nephropathy Autosomal Dominant Polycystic Kidney Disease

    Is XRTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 15 XORTX Therapeutics files to sell 810,810 common shares for holders
    Oct 24 XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2024
    Oct 18 XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement
    Oct 17 XORTX Therapeutics stock falls after pricing $1.5M capital raise
    Oct 17 XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement
    Oct 9 XORTX Initiates Precision Medicine Program
    Sep 13 XORTX Announces Results of Annual and Special Meeting of Shareholders
    Sep 12 XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A
    Sep 6 XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders
    Sep 3 Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders
    See more XRTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.0
    52 Week Low 1.09
    Average Volume 69,734
    200-Day Moving Average 2.34
    50-Day Moving Average 1.61
    20-Day Moving Average 1.46
    10-Day Moving Average 1.39
    Average True Range 0.18
    RSI (14) 40.48
    ADX 19.52
    +DI 16.52
    -DI 16.18
    Chandelier Exit (Long, 3 ATRs) 1.55
    Chandelier Exit (Short, 3 ATRs) 1.79
    Upper Bollinger Bands 1.67
    Lower Bollinger Band 1.25
    Percent B (%b) 0.09
    BandWidth 28.76
    MACD Line -0.08
    MACD Signal Line -0.07
    MACD Histogram -0.0111
    Fundamentals Value
    Market Cap 2.57 Million
    Num Shares 2 Million
    EPS -3.60
    Price-to-Earnings (P/E) Ratio -0.36
    Price-to-Sales 0.00
    Price-to-Book 0.76
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.50
    Resistance 3 (R3) 1.51 1.45 1.46
    Resistance 2 (R2) 1.45 1.40 1.44 1.45
    Resistance 1 (R1) 1.37 1.36 1.34 1.36 1.44
    Pivot Point 1.31 1.31 1.29 1.30 1.31
    Support 1 (S1) 1.23 1.26 1.20 1.22 1.14
    Support 2 (S2) 1.17 1.22 1.16 1.12
    Support 3 (S3) 1.09 1.17 1.11
    Support 4 (S4) 1.08